Gilead Coronavirus Drug Remdesivir Positive Recovery Results

#23545
ClemSnide
Participant

Baird Analyst Brian Skorney negative on Gilead

“Results should be very sobering: no effect on clinical improvement or mortality and maybe even more concerning, no effect on PCR. If remdesivir, as an antiviral, can’t even get an antiviral effect, it’s highly unlikely there will be any role, even in earlier stage patients.”

“It is unfortunate that this program did not work out, because it is obviously what is most readily available, but this was an obvious hail mary pass attempt that didn’t work out.””This is pretty close to a worst case scenario as not only did the clinical effect not manifest, but there wasn’t even an antiviral effect to explore” with apparent side effect imbalance showing potential safety risk.”

“This is pretty close to a worst case scenario as not only did the clinical effect not manifest, but there wasn’t even an antiviral effect to explore” with apparent side effect imbalance showing potential safety risk.